LYRA THERAPEUTICS INC (LYRA) Stock Analyst Ratings

NASDAQ:LYRA • US55234L2043

1.39 USD
+0.07 (+5.3%)
Last: Feb 13, 2026, 08:22 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to LYRA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 16.32. This target is 1074.1% above the current price.
  • LYRA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LYRA.
  • In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
  • LYRA was analyzed by 6 analysts. More opinions would make the average more meaningful.
LYRA Historical Analyst RatingsLYRA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.3916.1616.3216.3216.80 - 1,062.59% 1,074.10% 1,074.10% 1,108.63%
LYRA Current Analyst RatingLYRA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-08-14 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-06-10 HC Wainwright & Co. Maintains Neutral -> Neutral
2025-03-14 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-08-15 Cantor Fitzgerald Reiterate Overweight
2024-08-15 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-05-07 Jefferies Downgrade Buy -> Hold
2024-05-07 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-05-06 BTIG Downgrade Buy -> Neutral
2024-05-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-25 B of A Securities Maintains Buy -> Buy
2024-03-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-02 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-12 B of A Securities Maintains Buy -> Buy
2023-08-31 HC Wainwright & Co. Initiate Buy
2023-02-07 BTIG Maintains Buy
2022-05-24 Cantor Fitzgerald Initiate Overweight

LYRA THERAPEUTICS INC / LYRA FAQ

What is the price target for LYRA stock?

6 analysts have analysed LYRA and the average price target is 16.32 USD. This implies a price increase of 1074.1% is expected in the next year compared to the current price of 1.39.


How do analysts rate LYRA THERAPEUTICS INC (LYRA)?

The consensus rating for LYRA THERAPEUTICS INC (LYRA) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.